drugset
drugset / Trial / NCT00895544

Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Adults

NCT00895544 ↗

Phase 1/2 Completed 231 enrolled Alachua Government Services, Inc.
RandomizedParallel-groupOpen-labelPrevention

Summary

The main objective of the study is to assess the immune response to a non-adjuvanted H5N1 influenza vaccine in an adult population when administered according to a single prime-boost schedule.

Timeline

Start
2009-05
Primary completion
2010-10
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza vaccine (whole virion, Vero cell derived) Vaccine — —

Indications

avian influenza